Low PSA Score After Radiation Can Predict Prostate Cancer Return
A consortium of prostate cancer experts have discovered that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy to treat their cancer are less likely to have their prostate cancer return.
|
No Single Treatment is Best for Enlarged Prostate
About half of men with an enlarged prostate seek medical treatment because of bothersome urinary tract symptoms.
|
Men Have Time To Choose Best Prostate Cancer Treatment
While there is no medical benefit to postponing treatment for prostate cancer for six months, delaying treatment can allow a patient time to understand the options and pick the best.
|
Delayed Prostate Cancer Surgery Poses No Increased Risk for Some Patients
For carefully selected men with prostate cancer who are monitored, the window of cure does not close in the short term.
|
Researchers Discover New Virus in Prostate Tumors
The virus is 25 times more likely to be found in prostate cancer patients with a specific genetic mutation than men without the mutation.
|
Better Predictors for Outcomes After Radical Prostatectomy
Speed of PSA increase matters more than PSA level.
|
Prostate Cancer Detection In Young Men Requires Different Criteria For PSA Measurement
Prostate cancer in young men is not more aggressive and due to the lack of much concern it is recommended an active treatment approach in younger men.
|
Common Treatment for Osteoporosis May Help men with Prostate Cancer
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis.
|
New Radiation Therapy for Prostate Cancer Has Fewer Side Effects
A new radiation therapy for prostate cancer, Cesium 131 brachytherapy, has fewer side effects than other treatments.
|
Screening for Prostate Cancer May not Reduce Men's Risk of Death
Screening tests can increase the detection of prostate cancer, even at earlier stages, but not necessarily prolong prostate cancer survival.
|
Obesity May Make Diagnosing Prostate Cancer Harder
Diagnosing prostate cancer is a bit like finding a needle in a haystack and doctors may be missing cancers in obese men.
|
Model of Prostate Cancer Helps Identify Promising Pain Treatment
A new line of prostate cancer cells may provide a better model to study the disease. It identified a possible therapy to reduce prostate cancer pain.
|
NCI Launches Biorepository for Prostate Cancer
There is great potential for the use of biomarkers as a means of detecting and monitoring prostate cancer more effectively.
|
MUHC Advises and Reminds Men Over The Age of 50 to Get Annual Prostate Exam
Early warning signs of possible prostate cancer are: difficulty urinating, and urinating very often at night.
|
Long-term Hormone Use Helps Prostate Cancer Patients Live Longer
Treating high risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer.
|
Protein Suppresses Prostate Cancer
Prostate cancer is the most common type of cancer in U.S. men after skin cancer.
|
Fused Genes Trigger The Development of Prostate Cancer
The data in our study provides tantalizing evidence that gene fusion is the causative agent in prostate cancer.
|
New Method to Discover Gene Rearrangements That Can Aid in Detection of Early Prostate Cancer
The finding of a fused gene in prostate cancer is creating a new frontier in developing tests for earlier detection of prostate cancer.
|
Scientists Identify How Antibody Blocks Prostate Cancer Growth, May Lead To Targeted Treatment
This discovery on prostate cancer could pave the way for development of a new molecularly targeted prostate cancer treatment.
|
Obesity Associated with Cancer Progression Following Prostatectomy in Prostate Cancer
Men with early prostate cancer who are obese have a greater risk of cancer progression following a prostatectomy.
|
Treatment of Hormone Refractory Prostate Cancer with Quadramet and Taxotere
Treatment of advanced, hormone refractory prostate cancer with the chemotherapy drug Taxotere and Quadramet reduces prostate specific antigen (PSA) levels.
|
Obesity, History Of Weight Gain Could Help Predict Prostate Cancer Progression
Obesity may be closely associated with prostate cancer possibly increasing the odds of prostate cancer.
|
Can Pomegranates Prevent Prostate Cancer?
Pomegranate juice shows major promise to combat and treat prostate cancer.
|
Failure of PSA Levels To Fall In Prostate Cancer Patients May Lead To Poor Outcomes
Many men with relapsed prostate cancer will still have a median survival of more than a decade after being given hormonal treatment.
|
Does Lycopene Reduce The Risk of Prostate Cancer?
Men who eat plenty of tomato products, especially tomato sauce laden foods, have a lower risk of prostate cancer.
|
Researchers Identify New Blood Test for Prostate Cancer
Research identified a panel of 22 biomarkers that together more accurately predicted prostate cancer than the PSA test.
|
Protein Signatures for Prostate Cancer That Could Improve Diagnosis of Early Disease
Testing blood samples for antibodies that target prostate cancer cells may help identify patients with early stages of the disease.
|
Prostate Cancer Screening: What's The Use?
Prostate cancer screening usually means a blood test for prostate specific antigen (PSA) and might include a digital rectal examination (DRE) of the prostate.
|
Mutation May Raise Prostate Cancer Risk in African Americans
Prostate cancer rates are extremely high in African American men. They develop prostate cancer 60 percent more often than do European Americans
|
Lifestyle Changes May Slow Prostate Cancer Progression
Low grade prostate cancer may be slowed if men make healthful changes to their diet, physical activity level, and stress management techniques.
|
How Prostate Cancer Invades Bone
Prostate cancer often metastasizes to bone forming painful tumors. First step toward finding a way to block the development of metastatic bone tumors in men with prostate cancer.
|
High Dose Radiation Reduces Risk of Prostate Cancer Recurrence
When men with clinically localized prostate cancer are treated with high dose radiation therapy, they are more likely to be free from an increasing PSA level.
|
Ablatherm(r) HIFU Prostate Cancer Treatment a Safe Alternative
Ablatherm HIFU is a highly precise procedure using high intensity, focused ultrasound to eliminate prostate cancer.
|
Prostate Cancer Surgery Is Misleadingly Advertised
The usual prostate cancer operation is called the radical prostatectomy. It makes all men sterile and gives all men sexual dysfunction. The surgery leaves most men with a smaller penis, and there is significant risk of suffering impotence.
|
Presence of Activated Stat5 Protein in Prostate Cancer Can Predict Outcome
The findings may offer hope to identify patients who are more likely to have a recurring or life threatening prostate cancer.
|
Discovery of ETS Related Gene (erg) Offers Promising Lead in Prostate Cancer Diagnosis
Discovery provides a promising addition to a select group of genes, whose expression is frequently altered in prostate cancer cells and could provide novel molecular targets for diagnosis, prognosis or therapy of prostate cancer in the future.
|
Vitamin D, NSAIDS Provide Double Whammy Against Prostate Cancer
The growth of prostate cancer cells can be halted by combining a form of vitamin D, available only by prescription, with low doses of an over the counter painkiller.
|
Few Benefits, Many Costs Associated with Changing Definition of "Abnormal" PSA Level
Although it is easy to diagnose more prostate cancer, it is not easy to know who has clinically important disease.
|
Study Examines Accuracy of PSA Values for Detecting Prostate Cancer
A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer.
|
PSA Kinetics and Risk of Death From Prostate Cancer
Given recent randomized trials reporting significant improvement in survival with chemotherapy for patients with hormone refractory prostate cancer, a number of important questions persist.
|
